Bicyclic compounds with kinase inhibitory activity
申请人:Calderwood F. Emily
公开号:US20070149533A1
公开(公告)日:2007-06-28
The present invention provides novel bicyclic compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
METHOD OF PREPARING SILYLATIVE-REDUCED N-HETEROCYCLIC COMPOUND USING ORGANOBORON CATALYST
申请人:INSTITUTE FOR BASIC SCIENCE
公开号:US20170240572A1
公开(公告)日:2017-08-24
Provided is a method of preparing a silylative-reduced N-heterocyclic compound by reducing an N-heteroaromatic compound including a sp
2
hybridized nitrogen atom while simultaneously introducing a silyl group into a beta-position with respect to a nitrogen atom of the N-heteroaromatic compound, using a silane compound, in the presence of an organoboron catalyst.
US8110687B2
申请人:——
公开号:US8110687B2
公开(公告)日:2012-02-07
Unsupported Nanoporous Gold Catalyst for Highly Selective Hydrogenation of Quinolines
For the first time, the highly efficient and regioselective hydrogenation of quinolinederivatives to 1,2,3,4-tetrahydroquinolines using unsupported nanoporous gold (AuNPore) as a catalyst and organosilane with water as a hydrogen source is reported. The AuNPore catalyst can be readily recovered and reused without any loss of catalytic activity.